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The purpose of this study is to determine if microvascular tortuosity can be used as an imaging biomarker for the presence of
tumor-associated angiogenesis and if imaging this biomarker can be used as a specific and sensitive method of locating solid
tumors. Acoustic angiography, an ultrasound-based microvascular imaging technology, was used to visualize angiogenesis
development of a spontaneous mouse model of breast cancer (n = 48). A reader study was used to assess visual discrimination
between image types, and quantitative methods utilized metrics of tortuosity and spatial clustering for tumor detection. The
reader study resulted in an area under the curve of 0.8, while the clustering approach resulted in the best classification with an
area under the curve of 0.95. Both the qualitative and quantitative methods produced a correlation between sensitivity and
tumor diameter. Imaging of vascular geometry with acoustic angiography provides a robust method for discriminating between
tumor and healthy tissue in a mouse model of breast cancer. Multiple methods of analysis have been presented for a wide range
of tumor sizes. Application of these techniques to clinical imaging could improve breast cancer diagnosis, as well as improve
specificity in assessing cancer in other tissues. The clustering approach may be beneficial for other types of morphological
analysis beyond vascular ultrasound images.
1. Introduction
Clinical detection and diagnosis of breast cancer typically
begins with X-ray mammographic identification of a sus-
picious lesion, followed by diagnostic imaging with other
imaging modalities, often ultrasound. Mammography and
grayscale ultrasound utilize anatomic features of breast tissue
in order to discriminate malignant from benign breast tissue.
The Breast Imaging-Reporting and Data System (BI-RADS)
provides a framework for lesion ranking by probability of
disease based on a number of radiographic features [1, 2].
Although reported numbers are variable, the sensitivity of
screening mammography typically lies between 70% and
90% [3]. Ultrasound imaging can improve this sensitivity,
although the specificity of breast imaging using this combi-
nation is poor in women with dense breasts, as low as 40%
[3]. Furthermore, this limitation is even more significant
with women with prosthetic implants, where X-ray mam-
mography cannot penetrate silicone or saline effectively.
Universally, uncertain imaging results require biopsy, which
provides additional emotional stress, cost, and possibility
of complication to a large percentage of women who end
up with negative biopsy results after inconclusive imaging
[4, 5]. Additional imaging methods that could better iden-
tify malignancies could improve breast cancer detection
and ultimately reduce the number of unnecessary biopsies
performed each year.
Microvascular imaging approaches have been proposed
as an approach for cancer detection and diagnosis due to
the prevalence of pathological angiogenesis, a process in
which growing tumors quickly outpace their blood supply
and trigger the growth of new vasculature [6]. Angiogenesis
is recognized as a hallmark of cancer and a pervasive feature
of solid tumors. Notably, the newly formed vessels are dis-
tinct from healthy vasculature in several ways [7]. Cancer
neovasculature lacks regular hierarchical branching struc-
tures, leading to unpredictable flow and frequent arteriove-
nous shunts. The vessels are also immature and leaky and
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form tortuous, sinuous, and erratically shaped vessels [8–10].
Thus, perfusion patterns and abnormal vascular geometry
make likely biomarkers for improving sensitivity to disease.
Acoustic angiography is a method of contrast-enhanced
ultrasound imaging, and it detects broadband superharmo-
nic emissions from microbubbles by transmitting at a low
frequency and receiving with a higher frequency transducer,
several harmonics above that of the transmitted signal [11].
Tissue produces much less energy than microbubbles in the
superharmonic range, so imaging microbubbles with super-
harmonics enables high contrast-to-tissue ratios and high
resolution due to the high frequency receive [12, 13]. The
resulting images reveal that the morphology of vessels
resolved at 100-200μm in diameter and contrast signal from
vasculature with very little background signal. Acoustic angi-
ography has been utilized in small animal models where it
has enabled visualization of cancer-induced microvascular
angiogenesis and invasion. Using this technique, researchers
have observed microvascular patterns which exhibit signifi-
cant differences in both morphology and density of micro-
vasculature, in both rat and mouse tumor models [14–21].
It was also recently demonstrated to be feasible for imaging
microvasculature in humans, depicting breast vasculature as
small as 200μm to a depth of approximately 15mm [22].
Other ultrasound imaging approaches have been used for
visualizing tumor vasculature in clinical applications. Previ-
ous studies with Doppler and contrast-Doppler images of
breast lesions have found that the detection of penetrating
vessels is highly suggestive of malignancy [23–25]. Other fea-
tures visible in Doppler imaging that suggested malignancy
were hypervascularity and tortuosity. However, these stud-
ies lacked specificity and several false positives occurred
(primarily in cases of fibroadenomas). Contrast-enhanced
ultrasound imaging has also been investigated for breast can-
cer diagnosis, and features of contrast-enhanced ultrasound
(CEUS) imaging have been found to be correlated with
histological tumor features, especially microvessel density
[26]. Additionally, reader studies investigating clinical CEUS
imaging in tumors of other organs have shown that CEUS is
superior to unenhanced imaging in the liver [27–31], pan-
creas [32, 33], kidney [34], and bladder [35]. Though the
majority of ultrasound contrast studies are performed in
2D, Luo et al. acquired 3D CEUS images of liver lesions
and processed them to create “sonographic angiograms” to
display vascular structure [36]. They reported good reader
agreement, sensitivity, and specificity using diagnostic fea-
tures including ring-like enhancement, peripheral nodular
enhancement, and spoke-and-wheel arterial arrangements,
combined with the presence of early-phase enhancement.
Acoustic angiography can display 3D vascular morphol-
ogy of vessels as small as 100-200μm in diameter with high
contrast and provide information about vascular density for
vessels of all sizes. Therefore, we hypothesize that acoustic
angiography images may provide a sensitive and specific
diagnostic tool for cancer through the evaluation of vascular
features that are common in tumors.
This hypothesis has been tested here using two detection
approaches in a genetically engineered mouse model of
breast cancer. First, visual assessment with a reader study
mimics clinical practices for image-based diagnosis. Second,
a quantitative method uses spatial and geometric informa-
tion (tortuosity) to detect tumor presence using a statistical
clustering algorithm. The sensitivity and specificity of each
method are reported using receiver operating characteristic
(ROC) curves, and the relationships between robust lesion
identification and tumor size are explored.
2. Materials and Methods
The C3(1)/Tag mouse is a model of basal breast cancer in
which tumors develop spontaneously in the mammary
pads of female mice, becoming palpable around 16 weeks
of age [37]. Age-matched control mice were female wild-
type (FVB/NJ) littermates. This study included 48 mice: 31
C3(1)/Tag (tumors) and 17 FVB/NJ (controls). Mice were
monitored for tumor development using palpation and B-
mode imaging, and contrast images were acquired in mice
between 12 and 18 weeks old, as tumors emerged at different
times. The Institutional Animal Care and Use Committee
approved all protocols to ensure ethical standards for the
treatment of animals and compliance with federal regulations.
2.1. Image Acquisition. Images of the mammary pads in the
lower abdomen were collected while mice were anesthetized
with 1.5% vaporized isoflurane in oxygen, and temperature
was maintained with a heated stage. A 27-gauge catheter
was inserted into a tail vein for the administration of contrast
using a syringe pump (5 × 108 microbubbles per minute,
Harvard Apparatus, PHD2000). Fur was removed using clip-
pers and chemical depilation, and ultrasound gel was applied
to the imaging region.
Images were acquired with a modified Vevo 770 (Visual-
Sonics, Toronto, ON, CA) using a custom dual-element
RMV 707 which included a confocal 4MHz annular element
transducer for transmission in addition to a 30MHz receive
element. The driving waveform was a single-cycle, 1.2MPa,
4MHz pulse. Microbubbles used for this study were lipid-
shelled, perfluorocarbon agents similar to Definity (Lantheus
Medical Imaging 2017), approximately 1μm in diameter,
made in-house as described previously [16].
Contrast images resulted from transmitting with the low
frequency element and receiving the superharmonic signals
from excited microbubbles with the high frequency element,
and three-dimensional images were acquired using a linear
translation stage. Two images were averaged at each location,
with 100μm separating each frame. The frame rate was 4
frames per second, which resulted in an acquisition time of
approximately 1-2minutes for the 3D images encompassing
25mm × 25mm in the axial and lateral directions and 25-
30mm in the elevation direction. Tumor dimensions were
measured in 3 orthogonal axes from the B-mode images.
Tumor volumes were computed assuming ellipsoidal form,
and the geometric mean was used to represent the average
tumor diameter.
2.2. Qualitative Assessments. Visual image classification was
performed using a reader study design, and seven readers
with experience visualizing ultrasound images rated the
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likelihood of malignancy on a scale of 1-6. A user interface
was created using GUIDE (Graphical User Interface Devel-
opment Environment, MATLAB, The MathWorks, Inc.) to
display 3 views of each contrast image, which were presented
to readers in random order. Two views were 2D images in the
axial and coronal planes with scrollbars to allow for interac-
tive viewing of individual slices from the 3D image volume.
The third view was a maximum intensity projection of the
data in the coronal plane. Each image also displayed a small
red dot, indicating the suspicious region for the readers to
evaluate. In tumor images, the dot was placed at the center
of the tumor. In control images, the dot was positioned ran-
domly in the mammary pad. Localization was performed on
the B-mode images prior to study initiation, and coordinates
were transferred to the coregistered angiography images.
Readers were presented with the acoustic angiography
contrast images in random order and did not have access to
B-mode images. Readers used patterns of high vascular den-
sity, peripheral enhancement, tortuosity, tissue distortion,
and branching as indicators of tumor presence. The presence
of multiple features or very strong features increased the
readers’ confidence of malignancy.
Statistical analysis included calculation of receiver oper-
ating characteristic curves and interreader agreement and
was performed using STATA/SE 14.2, treating reader assess-
ments as ordinal variables. To characterize the relationship
between the readers’ performance and tumor diameter, we
applied ROC regression. The general ROC regression model
can be written as
ROCz pð Þ =Φ α1 + α2F−10,x pð Þ + β′z
n o
, ð1Þ
where F0,x is the survival function for controls with covariate
x, z = ðx, xDÞ, and x and xD are common and disease-specific
covariates, respectively. In the present study, we considered
the ROC regression model









dF−10,k pð Þ + βxg, ð2Þ
where dF−10,k is the empirical survival function for the controls
estimated for each reader k. The regression model was per-
formed using the rocreg fuction, and standard errors were
obtained using bootstrapping with 1000 replicates.
2.3. Quantitative Tortuosity Analysis. The images were also
analyzed using quantitative methods to assess vascular tortu-
osity. First, contrast images were exported and linearly inter-
polated in the elevation direction to create isotropic voxels.
Then, vessels were segmented using semiautomated multi-
scale ridge regression, using Aylward and Bullitt’s algorithm
[38]. Finally, tortuosity was calculated from the centerline
of each vessel using two metrics known as the distance metric
and the sum of angles metric after resampling the centerlines
to 50μm spacing between points [39].
The distance metric (DM) is defined as the cumulative
distance between consecutive points, p, along the centerline,
divided by the distance between the endpoints:
DM= ∑
n−1
x=1 px − px+1k k
px − pnk k
: ð3Þ
The sum of angles metric (SOAM) is the sum of the
angles between consecutive trios of points along the center-
line, normalized by the path length. The angle is calculated
by using the dot product of the two vectors defined by three
points, normalized to unit length, then calculating the angle
in radians using inverse cosine:
SOAM = ∑
n−2
x=1cos−1 νx/ νxk k ⋅ νx+1/ νx+1k kð Þ
∑n−1x=1 px − px+1k k
ð4Þ
Summary statistics of tortuosity parameters and ROC
curves were calculated in R using the pROC and ROCR pack-
ages [40–42]. Clustering analysis was performed using the
DBSCAN algorithm using the DBSCAN package in R [43],
with a minimum number of points per cluster of 4 and a
neighborhood size (ϵ) of 27.
3. Results and Discussion
The tumors included in this study ranged from 0.8mm to
8.2mm in diameter with a mean and standard deviation of
3:1 ± 2:20mm. The median size was 2.3mm, and the size dis-
tribution was skewed toward small tumors (<3mm) in order
to assess the efficacy of ultrasound vascular imaging for
tumor identification and to determine the influence of tumor
size on sensitivity. Tumors smaller than 3mm in diameter
are barely palpable in the mammary pads of mice but visible
in high frequency (30MHz) B-mode imaging, as shown in
Figure 1, which illustrates a typical image in the abdomen
of a healthy control as well as images from mice with tumors
0.8, 2.1, and 5.1mm in diameter.
Acoustic angiography contrast images, such as those
shown in Figures 2 and 3, reveal vascular cross-sections in
the axial and coronal planes and show longer vessel seg-
ments in coronal planes and maximum intensity projections.
Figure 2 illustrates typical contrast images of small tumors
less than 2mm in diameter. Figures 2(a) and 2(b) show axial
cross-sections through each tumor, with dense vasculature
and peripheral enhancement apparent. Figure 2(c) shows a
coronal projection, showing vascular tortuosity and branch-
ing. These features of vascular geometry are not seen in con-
trol images, such as those shown in Figure 3.
3.1. Reader Study Analysis. Readers independently completed
their assessments for all images in approximately two hours.
There was strong agreement between the seven readers,
reflected by a value of 0.778 for Kendall’s coefficient of con-
cordance, and no significant difference was found between
reader effects.
A receiver operator characteristic curve was constructed
from the aggregate results of all seven readers, which revealed
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an overall area under the curve of 0.798 with a 95% confi-
dence interval of 0.702-0.894, shown in Figure 4(a). The
overall AUC value indicates the classification performance
for this sample of data, which included tumors from a wide
size range of 0.8 to 8mm in diameter. The optimal cutoff,
with sensitivity and specificity weighed equally, resulted in
a specificity of 0.86 and a sensitivity of 0.65, at a reader assess-
ment rank of 3.
The overall performance of the study, represented by the
ROC curve, is dependent on the distribution of tumor sizes
included in the study. Therefore, in order to characterize
the relationship between reader performance and tumor
diameter, we applied ROC regression, as described in equa-
tion (2). Regression analysis indicated that tumor diameter
had a significant effect on the ROC curve, with p = 0:018
and a coefficient of 0.343. Figure 4(b) shows the expected
ROC curves for 3 different tumor sizes, chosen from the
quartiles of the tumor diameters: 1.37, 2.32, and 5.09mm.
The area under the ROC curve and 95% confidence intervals
for these tumor diameters are 0.670 (0.593, 0.766), 0.777
(0.723, 0.860), and 0.956 (0.907, 0.997), also listed in Table 1.
The average rating for a control image was 2:2 ± 0:5, with
most control images consistently rated between 1 and 3,
while the mean rating for tumors among all readers was
4:5 ± 1:4, with ratings for tumors being noticeably more var-
iable across tumor diameters. Figure 5 shows the mean reader
assessment rank for the 31 tumors versus tumor diameter.
Scores for the 21 tumors smaller than 3mm in diameter
received a wide range of scores between 1.57 and 5.86, with a
mean and standard deviation of 3:92 ± 1:35. However, the
10 tumors larger than 3mm in diameter received consistently
higher scores with a mean and standard deviation of 5:53 ±
0:7. These results suggest that tumor size strongly influenced
the ability of readers to identify the vascular geometry tumors.
Overall, the specificity of the reader study was better than
the sensitivity, meaning that false positives are uncommon
using the qualitative reader study approach for classification.
Different clinical applications may require different levels of
sensitivity or specificity to provide useful classification.
Table 2 lists the sensitivity and specificity values that result
from requiring either a sensitivity or a specificity level of 0.9.




Figure 1: Frames of high frequency B-mode images acquired in the abdomen of (a) control FVB/N and tumor-bearing (b–d) C3(1)\Tagmice.






Figure 2: Typical contrast images of microtumors. (a, b) 1.5 and 1.7mm tumors displaying patterns of vascular density, tortuosity, and
peripheral enhancement in axial frames. (c) Maximum intensity projection in the coronal view from (b).
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expected to be suboptimal when the other metric is required
to be 0.9, but for tumors approximately 5mm in diameter,
both the sensitivity and specificity are greater than 0.9.
3.2. Tortuosity Analysis and Clustering. Quantitative analysis
of tortuosity included calculations of the distance metric and
sum of angles metric for all vessels segmented in each image.
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Figure 4: (a) Overall ROC curve derived from the combined assessment of all 7 readers (AUC = 0:80). (b) Expected ROC curves for 3
different tumor sizes (AUC = 0:67, 0.78, and 0.96).
Table 1: Reader study ROC area under the curve values.
Quartile Diameter AUC Confidence intervala
1 1.37mm 0.670 0.593-0.766
2 (median) 2.32mm 0.777 0.723-0.860
3 5.09mm 0.956 0.907-0.997






Figure 3: (a, b) Axial frames from control mice. (c) Coronal frame with a red dot to guide the reader’s focus for assessment. (d) is the
maximum intensity projection image corresponding to (c).
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in order to compare tumor and control images using theWil-
coxon rank sum. The mean and standard deviation of the dis-
tance metric was 8:89 ± 22:24 in tumors and 2:20 ± 2:72 in
controls, with no significant difference between tumor
images and controls (p = 0:11). The mean and standard devi-
ation of the sum of angles metric was 3:61 ± 0:38 rad/mm
for tumors and 3:09 ± 0:57 rad/mm for controls, resulting
in a significant difference between the two groups, with p =
2:8 × 10−3.
The mean tortuosity metric can be used to classify an
image by setting a simple threshold to determine if the image
is more likely to belong to the tumor or the control group.
ROC analysis was used to determine the efficacy of classifica-
tion using mean tortuosity across the range of possible
thresholds. The AUC for the distance metric was 0.682, and
0.824 for the sum of angles metric and listed in Table 3. These
results are similar to the overall AUC found using the quali-
tative reader study approach (0.778). These results support
the hypothesis that tortuosity is higher in tumors than con-
trols and therefore can be used to determine if an individual
image contains a tumor, whether using visual or quantitative
methods of discrimination.
However, classification based on mean tortuosity dimin-
ishes the likelihood of detecting small tumors due to use of
the mean value to represent the population of vessels within
an entire image. Additionally, the use of summary statistics
neglects the predictive value of heterogeneity and spatial
information provided in the vascular images. Therefore, a
clustering approach known as Density-Based Spatial Cluster-
ing in Applications with Noise (DBSCAN) was used to pro-
duce a classifier that accounts for spatial heterogeneity.
The vessels in each image were grouped into clusters
using the DBSCAN algorithm, and maximum cluster size
was chosen as the most predictive parameter for image clas-
sification. Other potential classification metrics generated by
DBSCAN, such as total number of vessels clustered and num-
ber of clusters generated, had lower predictive value than the
maximum cluster size. The mean and standard deviation of
the maximum cluster size were much greater in tumor images
(33:84 ± 32:76) than control images (5:41 ± 1:42). ROC anal-
ysis of maximum cluster size for image classification resulted
in an area under the curve of 0.948 (95% CI: 0.829-0.977), as
seen in Figure 6(a) and Table 3.
Weighing sensitivity and specificity equally, the optimal
cutoff is a minimum cluster size of 8 vessels, resulting in a
sensitivity of 0.871 and a specificity of 0.941, with 95% confi-
dence intervals of 0.667-1.0 and 0.765-1.0, respectively. Max-
imum cluster size is positively correlated to tumor diameter,
with a significant linear regression resulting in p = 1:3 × 10−4
and R2 = 0:37, as seen in Figure 6(b). Density-based spatial
clustering of vessel-level tortuosity metrics provides the most
accurate detection of tumors in these acoustic angiography
images, with higher area under the ROC curve (0.95) than
both image-level statistical analysis and reader study-based
identification. The reader study approach resulted in an
AUC of approximately 0.8, with high reader agreement
(W = 0:778), and no significant differences between readers.
These results are consistent with the trends presented by a
previous study of 3D vascular morphology in liver tumors
[36]. Though reader agreement was good, there was greater
variation between the ratings of tumor images than those of
controls, especially in small tumors. The tumors with the
most variability in assessment level tended to have sparser
vascular patterns and features that were visible in some of
the 2D image frames but obscured in the maximum intensity
projections. This suggests that images with vascular abnor-
malities visible in the maximum intensity projection resulted


















Figure 5: Average assessment from 7 readers vs. tumor size. Tumors larger than 3mm received high ratings, indicating strong confidence of
tumor presence.









Table 3: Tortuosity and clustering ROC area under the curve
values.
Metric AUC Confidence intervala
Clustering 0.948 0.829-0.977
Mean SOAM 0.824 0.675-0.947
Mean DM 0.682 0.507-0.825
a95% confidence interval.
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Three-dimensional tortuosity in small vessels can be
difficult to identify in maximum intensity projections (such
as those seen in Figure 2), due to multiple vessels overlapping
each other in the projected volume, which can obscure the
morphology of individual vessels. Therefore, image segmen-
tation and quantitative analysis were also performed to calcu-
late vascular tortuosity, which can be displayed as 3D objects
instead of image projections, as seen in Figure 7. Two metrics
of tortuosity, the sum of angles metric and distance metric,
were computed, and the SOAM revealed a significant dif-
ference between tumor and control images while the DM
did not. However, mean values do not consider spatial
information, biasing the detection toward larger tumors.
Therefore, the most reliable classification method was using
the Density-Based Spatial Clustering in Applications with





































Figure 6: (a) ROC curves for differentiation between tumor and control images using tortuosity metrics. AUC = 0:95, 0.82, and 0.68. (b)
Scatterplot of tumor diameter versus maximum cluster size and linear regression line (p = 1:3 × 10−4 and R2 = 0:37).
(a) (b)
Figure 7: Renderings of segmented vasculature of tumors with color intensity showing tortuosity (SOAM). (a) shows a large tumor (5.1mm)
and (b) shows a smaller tumor (3.5mm) with a cluster of tortuous vessels in the tumor region indicated by an arrow.
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tortuosity data and using the size of the cluster as a prediction
metric. In this study of 48 images, tortuosity clustering-
based classification resulted in an excellent area under the
curve of 0.95.
This study demonstrates the performance of acoustic
angiography for distinguishing tumors from healthy control
tissue through a reader study approach and using quantita-
tive analysis of vascular geometry. Both methods resulted in
AUCs of 0.8 or better, but classification using clustering of
quantitative tortuosity metrics yielded the highest AUC of
0.95. Unsurprisingly, both methods showed that the sensitiv-
ity of detection depended on the tumor diameter, with larger
tumors detected with more accuracy. However, performance
was still notable for tumors on the order of 5mm, which
would be considered very small in clinical diagnostics.
These results support the potential diagnostic benefit of
microvascular imaging techniques in improving sensitivity
and specificity over grayscale ultrasound. In addition to
acoustic angiography, the technique of ultrasound localiza-
tion microscopy (ULM), also referred to as super resolution
(ultrasound) imaging, can provide even higher resolution
microvascular images than described here [19, 44, 45] and
can be combined with acoustic angiography in order to
reduce the ULM preprocessing to separate microbubbles
from the tissue clutter [46]. Although ULM still faces chal-
lenges with long acquisition and processing times for 3D data
sets, it has the potential to resolve microvasculature smaller
than 20 microns. Similarly, we hypothesize that photoacous-
tic imaging, which has similar capability to image the micro-
vasculature in vivo [47], could also be used as a tool to
identify the presence of malignant angiogenesis. A discussion
of acoustic angiography relative to photoacoustic imaging
has been provided previously by Gessner et al. [11].
4. Conclusions
An imaging technique with high resolution and high contrast
to display vascular morphology has the potential to improve
tumor diagnosis through the identification of the vascular
features unique to tumor angiogenesis. Acoustic angiogra-
phy, a contrast-enhanced ultrasound image technique, uses
microbubble superharmonics to selectively image microvas-
culature as small as 100-200μm. These images can be used
to identify images of tumors in a mouse model of breast
cancer. Sensitivity was correlated to tumor diameter using
visual assessment and quantitative approaches. The best
discrimination was generated using a statistical clustering
algorithm to identify clusters of tortuous vessels in images.
This method resulted in an excellent area under the curve of
0.95 in a sample of 48 images with tumors ranging from 0.8
to 8mm in diameter.
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